Catalyst Biosciences Inc (NASDAQ: GYRE) stock closed at $11.12 on 12/17/24 after a major increase of 11.3%. NORMAL trading volume accompanied the advance. The stock has risen 3.5% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment